ABERRANT SPLICING DURING ERYTHROID DIFFERENTIATION IN SF3B1 MUTATED SIDEROBLASTIC

被引：0
|
作者：
Conte, S. [1 ]
Vesterlund, L. [2 ,3 ]
Katayama, S. [2 ,3 ,4 ]
Karimi, M. [1 ]
Unneberg, P. [5 ]
Papaemmanuil, E. [6 ]
Jansson, M. [1 ]
Mortera-Blanco, T. [1 ]
Dimitriou, M. [1 ]
Sander, B. [7 ]
Skoog, T. [2 ,3 ]
Campbells, P. [6 ]
Kere, J. [2 ,3 ]
Hellstrom-Lindberg, E. [1 ]
机构：
[1] Ctr Hematol & Regenerat Med HERM, Dept Med, Huddinge, Sweden
[2] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden
[3] Karolinska Inst, Ctr Biosci, Stockholm, Sweden
[4] Sci Life Lab, Stockholm, Sweden
[5] Sci Life Lab, Dept Biochem & Biophys, Stockholm, Sweden
[6] Wellcome Trust Sanger Inst, Canc Genet & Genom, Cambridge, England
[7] Karolinska Univ Hosp, Div Pathol, Dept Lab Med, Stockholm, Sweden
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P168
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [1] Aberrant splicing during erythroid differentiation in SF3B1 mutated sideroblastic anemia
    Conte, S.
    Vesterlund, L.
    Katayama, S.
    Karimi, M.
    Unneberg, P.
    Papaemmanuil, E.
    Jansson, M.
    Mortera-Blanco, T.
    Dimitriou, M.
    Sander, B.
    Skoog, T.
    Campbell, P.
    Kere, J.
    Hellstrom-Lindberg, E.
    LEUKEMIA RESEARCH, 2013, 37 : S24 - S25
  • [2] SF3B1 MUTATIONS INDUCE ABERRANT SPLICING LEADING TO A BLOCK IN ERYTHROID DIFFERENTIATION AND COMPETITIVE ADVANTAGE
    Buonamici, S.
    Perino, S.
    Lim, K.
    Darman, R.
    Feala, J.
    Peng, S.
    Bhavsar, E.
    Corson, L.
    Keaney, G.
    Mizui, Y.
    Obeng, E.
    Park, E.
    Wang, J.
    Warmuth, M.
    Yu, L.
    Zhu, P.
    Furman, R.
    Ebert, B.
    Smith, P.
    LEUKEMIA RESEARCH, 2015, 39 : S9 - S9
  • [3] Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation
    Conte, Simona
    Vesterlund, Liselotte
    Katayama, Shintaro
    Karimi, Mohsen
    Papaemmanuil, Elli
    Jansson, Monika
    Mortera-Blanco, Teresa
    Dimitriou, Marios
    Sander, Birgitta
    Skoog, Tiina
    Campbell, Peter J.
    Kere, Julia
    Unneberg, Per
    Hellstroem-Lindberg, Eva
    BLOOD, 2013, 122 (21)
  • [4] Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
    Conte, Simona
    Katayama, Shintaro
    Vesterlund, Liselotte
    Karimi, Mohsen
    Dimitriou, Marios
    Jansson, Monika
    Mortera-Blanco, Teresa
    Unneberg, Per
    Papaemmanuil, Elli
    Sander, Birgitta
    Skoog, Tiina
    Campbell, Peter
    Walfridsson, Julian
    Kere, Juha
    Hellstrom-Lindberg, Eva
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 478 - 490
  • [5] Cancer-Associated Mutations in SF3B1 Exhibit Neomorphic Splicing Activity and Block Erythroid Differentiation
    Buonamici, Silvia
    Perino, Samantha
    Lim, Kian Huat
    Feala, Jacob
    Obeng, Esther A.
    Aicher, Michelle
    Aird, Daniel
    Bailey, Suzanna
    Berkenblit, Anna
    Chan, Betty
    Erik, Corcoran
    Corson, Laura
    Darman, Rachel
    Fekkes, Peter
    Furman, Richard R.
    Keaney, Gregg F.
    Kumar, Pavan
    Kunii, Kaiko
    Lee, Linda
    Mackenzie, Crystal
    Park, Eunice
    Puyang, Xiaoling
    Selvaraj, Anand
    Thomas, Michael
    Wang, John
    Warmuth, Markus
    Yu, Lihua
    Zhu, Ping
    Mizui, Yoshiharu
    Ebert, Benjamin L.
    Smith, Peter G.
    BLOOD, 2014, 124 (21)
  • [6] SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
    V Visconte
    H Makishima
    A Jankowska
    H Szpurka
    F Traina
    A Jerez
    C O'Keefe
    H J Rogers
    M A Sekeres
    J P Maciejewski
    R V Tiu
    Leukemia, 2012, 26 : 542 - 545
  • [7] SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
    Visconte, V.
    Makishima, H.
    Jankowska, A.
    Szpurka, H.
    Traina, F.
    Jerez, A.
    O'Keefe, C.
    Rogers, H. J.
    Sekeres, M. A.
    Maciejewski, J. P.
    Tiu, R. V.
    LEUKEMIA, 2012, 26 (03) : 542 - 545
  • [8] THE SPLICEOSOMAL COMPONENT SF3B1 IS ESSENTIAL FOR HEMATOPOIETIC DIFFERENTIATION AND SPLICING FIDELITY
    Bowman, Teresa
    Cameron, Rosannah
    McKinstry, Mia
    De La Garza, Adriana
    Nik, Sara
    Payne, Sara
    Smith, Peter
    Buonamici, Silvia
    Bradley, Robert
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S51 - S51
  • [9] Novel SF3B1 deletion mutations result in aberrant RNA splicing in CLL patients
    Agrawal, Anant A.
    Seiler, Michael
    Brinton, Lindsey
    Mantel, Rose
    Lapalombella, Rosa
    Woyach, Jennifer A.
    Johnson, Amy J.
    Yu, Lihua
    Byrd, John C.
    Smith, Peter G.
    Blachly, James S.
    Buonamici, Silvia
    CANCER RESEARCH, 2017, 77
  • [10] Mutations in SF3B1 lead to aberrant splicing through cryptic 3′ splice site selection and impair hematopoietic cell differentiation
    Buonamici, Silvia
    Perino, Samantha
    Lim, Kian Huat
    Feala, Jacob
    Darman, Rachel
    Obeng, Esther
    Furman, Richard R.
    Bailey, Suzanna
    Keaney, Gregg
    Kumar, Pavan
    Mizui, Yoshiharu
    Park, Eunice
    Wang, John
    Warmuth, Markus
    Yu, Lihua
    Zhu, Ping
    Ebert, Benjamin L.
    Smith, Peter
    CANCER RESEARCH, 2015, 75
12345